• Title of article

    SAR studies of 6-aryl-1,3-dihydrobenzimidazol-2-ones as progesterone receptor antagonists

  • Author/Authors

    Eugene A. Terefenko، نويسنده , , Jeffrey Kern، نويسنده , , Andrew Fensome، نويسنده , , Jay Wrobel، نويسنده , , Yuan Zhu، نويسنده , , Jeffrey Cohen، نويسنده , , Richard Winneker، نويسنده , , Zhiming Zhang، نويسنده , , Puwen Zhang، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2005
  • Pages
    4
  • From page
    3600
  • To page
    3603
  • Abstract
    We have previously reported that the aryl substituted benzimidazolones, benzoxazinones, and oxindoles (e.g., 1–3) are progesterone receptor (PR) antagonists and have recently disclosed that the nature of 5- and 6-aryl moieties played a critical role in PR functional activity in the oxindole and benzoxazinone templates. For example, replacing the phenyl group of PR antagonists 2 and 3 with a 5′-cyanopyrrol-2′-yl moiety switched their functional activity to PR agonist activity (2a and 3a). These findings prompted us to examine if there is a similar effect of the 6-aryl moieties on the PR functional activity for the benzimidazolone template. Numerous analogs, such as 5, showed potent PR antagonist activity with about a 10-fold increase in potency as compared to those reported earlier in the same series. More interestingly, pyrrole-containing benzimidazolones 24–27 remained as PR antagonists in contrast to the PR agonist activity switch for oxindole and benzoxazinone scaffolds when a 5′-cyanopyrrol-2′-yl group was installed as a pendant aryl group.
  • Journal title
    Bioorganic & Medicinal Chemistry Letters
  • Serial Year
    2005
  • Journal title
    Bioorganic & Medicinal Chemistry Letters
  • Record number

    795842